With 0.61 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.65 million shares. During the session, the Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $5.31 whereas the lowest price it dropped to was $5.2. The 52-week range on BAK shows that it touched its highest point at $10.98 and its lowest point at $5.28 during that stretch. It currently has a 1-year price target of $8.82. Beta for the stock currently stands at 2.01.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BAK was down-trending over the past week, with a drop of -13.75%, but this was down by -19.66% over a month. Three-month performance dropped to -13.32% while six-month performance fell -29.73%. The stock lost -33.29% in the past year, while it has lost -40.25% so far this year. A look at the trailing 12-month EPS for BAK yields -3.54 with Next year EPS estimates of 0.11. For the next quarter, that number is -0.13. This implies an EPS growth rate of 18.17% for this year and 106.10% for next year.
Float and Shares Shorts:
At present, 172.53 million BAK shares are outstanding with a float of 172.20 million shares on hand for trading. On 2024-10-31, short shares totaled 1.56 million, which was 38.99999999999999 higher than short shares on 1727654400. In addition to Mr. Roberto Bischoff as the firm’s Chief Executive Officer, Mr. Pedro van Langendonck Teixeira de Freitas serves as its CFO and Head of Procurement & Institutional Relation.
Institutional Ownership:
Through their ownership of 0.04271 of BAK’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, BAK reported revenue of $19075000000.0 and operating income of -$119000000.0. The EBITDA in the recently reported quarter was $904000000.0 and diluted EPS was -$9.375528.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With BAK analysts setting a high price target of 12.0 and a low target of 8.0, the average target price over the next 12 months is 9.67629. Based on these targets, BAK could surge 127.7% to reach the target high and rise by 51.8% to reach the target low. Reaching the average price target will result in a growth of 83.61% from current levels.
Analysts have provided yearly estimates in a range of -$8.63531 being high and -$9.72086 being low. For BAK, this leads to a yearly average estimate of -$9.17212.
